Relative Efficacy of 225Ac-PSMA-617 and 177Lu-PSMA-617 in Prostate Cancer Based on Subcellular Dosimetry
Sign Up to like & getrecommendations! Published in 2022 at "Molecular Imaging and Radionuclide Therapy"
DOI: 10.4274/mirt.galenos.2021.63308
Abstract: Objectives: Radionuclide therapy targeting prostate-specific membrane antigen (PSMA) with alpha-emitting 225Ac-PSMA-617 has shown clinical efficacy even in cases of failed therapy with beta-emitting 177Lu-PSMA-617. We investigated the efficacy of 225Ac-PSMA-617 relative to 177Lu-PSMA-617 using subcellular… read more here.
Keywords: psma 617; 177lu psma; efficacy 225ac; psma ... See more keywords